Kegg medicus dgroup
| DG01922 | |
| DG番号 | DG01922 |
| 分類 | DGroup |
| 名称 | Selective COX2 inhibitor TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG01907 Anti-inflammatory drug, coxibs D00567 Celecoxib (JP18/USP/INN) D00568 Rofecoxib (JAN/USAN/INN) D02709 Valdecoxib (USAN/INN) DG00759 Parecoxib D03716 Parecoxib (USAN/INN) D03717 Parecoxib sodium (USAN) D03710 Etoricoxib (USAN/INN) D03714 Lumiracoxib (USAN/INN) D10656 Polmacoxib (USAN/INN) D01974 Tilmacoxib (JAN/USAN/INN) D03689 Deracoxib (USAN) D03712 Firocoxib (USAN/INN) D04863 Mavacoxib (USAN) D08657 Apricoxib (USAN/INN) D00315 Etodolac (JP18/USP/INN) D01866 Lornoxicam (JAN/USAN/INN) D00969 Meloxicam (JAN/USP/INN) D00425 Nabumetone (JP18/USP/INN) D01547 Zaltoprofen (JP18/INN) |
| 上位グループ | Anti-inflammatory DG01504 Nonsteroidal anti-inflammatory drug (NSAID) |
| 注釈1 | - |
| 注釈2 | - |